Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study

NCT02486445 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

625

Enrollment

OTHER

Sponsor class

Conditions

Deep Venous Thrombosis

Interventions

DRUG: Rivaroxaban

Sponsor

Ostfold Hospital Trust